US removes Black Box Warnings from three estrogen patch products

The US regulator has approved the removal of broad black box warnings from three estrogen patch products used to treat menopause symptoms. The decision follows a review of existing safety labelling and aims to ensure warnings appropriately reflect risks while improving access to hormone replacement therapies amid rising demand.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.